Geneos Wealth Management’s Franklin US Core Dividend Tilt Index ETF UDIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.5K Hold
491
﹤0.01% 1668
2026
Q1
$25.3K Sell
491
-2
-0.4% -$107 ﹤0.01% 1686
2025
Q4
$26.2K Sell
493
-5
-1% -$264 ﹤0.01% 1632
2025
Q3
$26.1K Hold
498
﹤0.01% 1621
2025
Q2
$24K Buy
498
+5
+1% +$222 ﹤0.01% 1940
2025
Q1
$21.6K Sell
493
-115
-19% -$5.26K ﹤0.01% 1913
2024
Q4
$27.6K Sell
608
-48
-7% -$2.2K ﹤0.01% 1583
2024
Q3
$29.3K Sell
656
-50
-7% -$2.15K ﹤0.01% 1403
2024
Q2
$29.7K Sell
706
-114
-14% -$4.61K ﹤0.01% 1239
2024
Q1
$33.1K Buy
820
+235
+40% +$9.04K ﹤0.01% 1210
2023
Q4
$21.6K Sell
585
-73
-11% -$2.52K ﹤0.01% 1326
2023
Q3
$21.8K Buy
+658
New +$22.7K ﹤0.01% 1348

Other funds holding UDIV

Geneos Wealth Management's UDIV Position: Q2 2026 in Review

Geneos Wealth Management held its Franklin US Core Dividend Tilt Index ETF (UDIV) position steady in Q2 2026 at 491 shares worth $29.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1668.

Geneos Wealth Management first reported a position in UDIV in Q3 2023 and has held it in 12 quarters since. The position peaked at $33.1K in Q1 2024. 43 funds tracked by Wall St. Rank hold UDIV as of Q2 2026.

  • Geneos Wealth Management held 491 shares of Franklin US Core Dividend Tilt Index ETF worth $29.5K as of Q2 2026.
  • Geneos Wealth Management left its Franklin US Core Dividend Tilt Index ETF share count unchanged in Q2 2026.
  • Franklin US Core Dividend Tilt Index ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1668 holding.
  • Geneos Wealth Management first reported a position in Franklin US Core Dividend Tilt Index ETF in Q3 2023 and has held it in 12 quarters since.
  • Geneos Wealth Management's Franklin US Core Dividend Tilt Index ETF position peaked at $33.1K in Q1 2024.
  • 43 funds tracked by Wall St. Rank held Franklin US Core Dividend Tilt Index ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.